Skip to main content
. 2013 Jun 19;154(9):3219–3227. doi: 10.1210/en.2012-2208

Figure 3.

Figure 3.

GH activates STAT5 and ERK in breast cancer cells. A, T47D cells were treated for 30 minutes with GH, E2, or both. Phospho- and total STAT5 and ERK levels were assessed by Western blot. B, T47D cells were pretreated for 2 hours with vehicle (dimethylsulfoxide) or inhibitors for EGFR (AG1478, 15 μM) or JAK2 (AZD1480, 1 μM), followed by treatment with GH+E2 for 30 minutes.